Processa Pharmaceuticals Statistics Share Statistics Processa Pharmaceuticals has 11.88M
shares outstanding. The number of shares has increased by 29.84%
in one year.
Shares Outstanding 11.88M Shares Change (YoY) 29.84% Shares Change (QoQ) 0.34% Owned by Institutions (%) 4.19% Shares Floating 10.44M Failed to Deliver (FTD) Shares 372 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 703.43K, so 5.92% of the outstanding
shares have been sold short.
Short Interest 703.43K Short % of Shares Out 5.92% Short % of Float 6.2% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.23 and the forward
PE ratio is -0.33.
Processa Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.23 Forward PE -0.33 PS Ratio 0 Forward PS 0 PB Ratio 1.59 P/FCF Ratio -0.24 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Processa Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.22,
with a Debt / Equity ratio of 0.04.
Current Ratio 1.22 Quick Ratio 1.22 Debt / Equity 0.04 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.19M Employee Count 10 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -81.82% in the
last 52 weeks. The beta is 1.37, so Processa Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.37 52-Week Price Change -81.82% 50-Day Moving Average 0.27 200-Day Moving Average 0.8 Relative Strength Index (RSI) 57.04 Average Volume (20 Days) 4,020,246
Income Statement
Revenue n/a Gross Profit n/a Operating Income -12.05M Net Income -11.85M EBITDA -11.85M EBIT -11.85M Earnings Per Share (EPS) -3.62
Full Income Statement Balance Sheet The company has 1.19M in cash and 73.51K in
debt, giving a net cash position of 1.12M.
Cash & Cash Equivalents 1.19M Total Debt 73.51K Net Cash 1.12M Retained Earnings -87.22M Total Assets 4.81M Working Capital 2.47M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.25M
and capital expenditures -3.24K, giving a free cash flow of -11.25M.
Operating Cash Flow -11.25M Capital Expenditures -3.24K Free Cash Flow -11.25M FCF Per Share -3.68
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PCSA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PCSA is $6,
which is 1900% higher than the current price. The consensus rating is "Buy".
Price Target $6 Price Target Difference 1900% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 22, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Jan 22, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -30.25 Piotroski F-Score 1
